Table of Contents
ISRN Gastroenterology
Volume 2012, Article ID 462642, 7 pages
http://dx.doi.org/10.5402/2012/462642
Research Article

Trends in Early Outpatient Drug Therapy in Pediatric Inflammatory Bowel Disease in Finland: A Nationwide Register-Based Study in 1999–2009

1Research Department, The Social Insurance Institution (Kela), 20720 Turku, Finland
2Children's Hospital, Helsinki University Central Hospital, University of Helsinki, P.O. Box 281, 00029 Helsinki, Finland

Received 25 May 2012; Accepted 25 June 2012

Academic Editors: J. M. Pajares, C.-T. Shun, and C. F. Sier

Copyright © 2012 Lauri J. Virta and Kaija-Leena Kolho. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Hildebrand, Y. Finkel, L. Grahnquist, J. Lindholm, A. Ekbom, and J. Askling, “Changing pattern of paediatric inflammatory bowel disease in Northern Stockholm 1990–2001,” Gut, vol. 52, no. 10, pp. 1432–1434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Perminow, S. Brackmann, L. G. Lyckander et al., “A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005–07, showing increased incidence in Crohn's disease,” Scandinavian Journal of Gastroenterology, vol. 44, no. 4, pp. 446–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. I. Benchimol, K. J. Fortinsky, P. Gozdyra, M. Van den Heuvel, J. Van Limbergen, and A. M. Griffiths, “Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends,” Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 423–439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Lehtinen, M. Ashorn, S. Iltanen et al., “Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study,” Inflammatory Bowel Diseases, vol. 17, no. 8, pp. 1778–1783, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Kappelman, C. Q. Porter, J. A. Galanko et al., “Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 62–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Kappelman, S. L. Rifas-Shiman, K. Kleinman et al., “The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States,” Clinical Gastroenterology and Hepatology, vol. 5, no. 12, pp. 1424–1429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Griffiths and H. B. Buller, “Inflammatory bowel disease,” in Pediatric Gastrointestinal Disease, W. A. Walker, P. R. Durie, J. R. Hamilton, J. A. Walker-Smith, and J. B. Waktinks, Eds., pp. 613–652, Decker, Ontario, Canada, 3rd edition, 2000. View at Google Scholar
  8. P. Turunen, M. Ashorn, A. Auvinen, S. Iltanen, H. Huhtala, and K.-L. Kolho, “Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study,” Inflammatory Bowel Diseases, vol. 15, no. 1, pp. 56–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. B. Heyman, B. S. Kirschner, B. D. Gold et al., “Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry,” Journal of Pediatrics, vol. 146, no. 1, pp. 35–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Van Assche, A. Dignass, W. Reinisch et al., “The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations,” Journal of Crohn's and Colitis, vol. 4, no. 1, pp. 63–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Tomomasa, A. Kobayashi, K. Ushijima et al., “Guidelines for treatment of ulcerative colitis in children,” Pediatrics International, vol. 46, no. 4, pp. 494–496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. C. Wilson, A. G. Thomas, N. M. Croft et al., “Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, supplement 1, pp. S14–S34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. P. L. Travis, E. F. Stange, M. Lémann et al., “European evidence-based Consensus on the management of ulcerative colitis: current management,” Journal of Crohn's and Colitis, vol. 2, no. 1, pp. 24–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kornbluth, D. B. Sachar, and Practice Parameters Committee of the American College of Gastroenterology, “Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee,” American Journal of Gastroenterology, vol. 105, no. 3, pp. 501–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Mowat, A. Cole, A. Windsor et al., “Guidelines for the management of inflammatory bowel disease in adults,” Gut, vol. 60, no. 5, pp. 571–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. M. Ruemmele, “Immunomodulation with methotrexate: underused and undervalued?” Digestive Diseases, vol. 27, no. 3, pp. 312–314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Martín-de-Carpi, N. Pociello, and V. Varea, “Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies,” Journal of Crohn's and Colitis, vol. 4, no. 5, pp. 594–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. I. de Bie, J. C. Escher, and L. de Ridder, “Antitumor necrosis factor treatment for pediatric inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 18, pp. 985–1002, 2012. View at Google Scholar
  19. S. M. Devlin and R. Panaccione, “Evolving inflammatory bowel disease treatment paradigms:top-down versus step-up,” Gastroenterology Clinics of North America, vol. 38, no. 4, pp. 577–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Burger and S. Travis, “Conventional medical management of inflammatory bowel disease,” Gastroenterology, vol. 140, no. 6, pp. 1827–1837, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Turner, S. P. L. Travis, A. M. Griffiths et al., “Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the porto IBD working group of ESPGHAN,” American Journal of Gastroenterology, vol. 106, no. 4, pp. 574–588, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. D. Kappelman, A. Bousvaros, J. Hyams et al., “Intercenter variation in initial management of children with Crohn's disease,” Inflammatory Bowel Diseases, vol. 13, no. 7, pp. 890–895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Hyams, T. Lerer, D. Mack et al., “Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study,” American Journal of Gastroenterology, vol. 106, no. 5, pp. 981–987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Jakobsen, P. Munkholm, A. Paerregaard, and V. Wewer, “Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators—a population-based study,” Inflammatory Bowel Diseases, vol. 17, no. 8, pp. 1731–1740, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Markowitz, J. Hyams, D. Mack et al., “Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes of newly diagnosed children with Crohn's disease,” Clinical Gastroenterology and Hepatology, vol. 4, no. 9, pp. 1124–1129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Hyams, J. Markowitz, T. Lerer et al., “The natural history of corticosteroid therapy for ulcerative colitis in children,” Clinical Gastroenterology and Hepatology, vol. 4, no. 9, pp. 1118–1123, 2006. View at Publisher · View at Google Scholar
  27. J. Markowitz, K. Grancher, N. Kohn, and F. Daum, “Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990–2000,” American Journal of Gastroenterology, vol. 97, no. 4, pp. 928–932, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Furu, B. Wettermark, M. Andersen, J. E. Martikainen, A. B. Almarsdottir, and H. T. Sørensen, “The Nordic countries as a cohort for pharmacoepidemiological research,” Basic and Clinical Pharmacology and Toxicology, vol. 106, no. 2, pp. 86–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. H. G. Beardon, M. M. McGilchrist, A. D. McKendrick, D. G. McDevitt, and T. M. MacDonald, “Primary non-compliance with prescribed medication in primary care,” British Medical Journal, vol. 307, no. 6908, pp. 846–848, 1993. View at Google Scholar · View at Scopus